Paper9736573
Single-dose pharmacokinetics of meropenem during continuous venovenous hemofiltration.
Thalhammer F and 8 others. Antimicrob Agents Chemother, 1998. Cited by 87 papers, by iCite.
Cite this record
ConductScience Library. Single-dose pharmacokinetics of meropenem during continuous venovenous hemofiltration. Papers, record 9736573. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/9736573
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics8
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Hemofiltration | Major topic |
| Thienamycins | Major topic |
| Aged | |
| Female | |
| Humans | |
| Male | |
| Meropenem | |
| Middle Aged |
Source PubMed
References24
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 7803882 | Meropenem: a new carbapenem antimicrobial. | Ann Pharmacother | 1994 | https://conductscience.org/library/papers/7803882 | PubMed |
| 2 | 3163038 | Pump assisted continuous venovenous hemofiltration for treating acute uremia. | Kidney Int Suppl | 1988 | https://conductscience.org/library/papers/3163038 | PubMed |
| 3 | 1482127 | Continuous infusion of beta-lactam antibiotics. | Antimicrob Agents Chemother | 1992 | https://conductscience.org/library/papers/1482127 | PubMed |
| 4 | 1802557 | Drug removal during continuous hemofiltration or hemodialysis. | Contrib Nephrol | 1991 | https://conductscience.org/library/papers/1802557 | PubMed |
| 5 | 8647616 | Basic mechanisms and definitions for continuous renal replacement therapies. | Int J Artif Organs | 1996 | https://conductscience.org/library/papers/8647616 | PubMed |
| 6 | 7593908 | Pharmacokinetics of continuous renal replacement therapy. | Intensive Care Med | 1995 | https://conductscience.org/library/papers/7593908 | PubMed |
| 7 | 9420033 | Pharmacokinetics of imipenem-cilastatin in critically ill patients undergoing continuous venovenous hemofiltration. | Antimicrob Agents Chemother | 1997 | https://conductscience.org/library/papers/9420033 | PubMed |
| 8 | 9200809 | Single-dose pharmacokinetics of teicoplanin during hemodialysis therapy using high-flux polysulfone membranes. | Wien Klin Wochenschr | 1997 | https://conductscience.org/library/papers/9200809 | PubMed |
| 9 | 2512140 | In vitro antibacterial activity and beta-lactamase stability of the new carbapenem SM-7338. | Eur J Clin Microbiol Infect Dis | 1989 | https://conductscience.org/library/papers/2512140 | PubMed |
| 10 | 8452352 | Pharmacokinetics of meropenem in patients with various degrees of renal function, including patients with end-stage renal disease. | Antimicrob Agents Chemother | 1993 | https://conductscience.org/library/papers/8452352 | PubMed |
| 11 | 1510437 | Removal of vancomycin by high-flux hemodialysis membranes. | Antimicrob Agents Chemother | 1992 | https://conductscience.org/library/papers/1510437 | PubMed |
| 12 | 8626257 | Antimicrobial prescribing in patients on haemofiltration. | J Antimicrob Chemother | 1995 | https://conductscience.org/library/papers/8626257 | PubMed |
| 13 | 8988066 | Multiple-dose pharmacokinetics of cefpirome in long-term hemodialysis with high-flux membranes. | Clin Pharmacol Ther | 1996 | https://conductscience.org/library/papers/8988066 | PubMed |
| 14 | 2770120 | Markedly increased clearance of vancomycin during hemodialysis using polysulfone dialyzers. | Kidney Int | 1989 | https://conductscience.org/library/papers/2770120 | PubMed |
| 15 | 1510451 | Pharmacokinetics of meropenem in subjects with various degrees of renal impairment. | Antimicrob Agents Chemother | 1992 | https://conductscience.org/library/papers/1510451 | PubMed |
| 16 | 8430678 | Comparison of imipenem pharmacokinetics in patients with acute or chronic renal failure treated with continuous hemofiltration. | Am J Kidney Dis | 1993 | https://conductscience.org/library/papers/8430678 | PubMed |
| 17 | 7652504 | Laboratory data which differentiate meropenem and imipenem. | Scand J Infect Dis Suppl | 1995 | https://conductscience.org/library/papers/7652504 | PubMed |
| 18 | 9174173 | Antimicrobial effects of continuous versus intermittent administration of carbapenem antibiotics in an in vitro dynamic model. | Antimicrob Agents Chemother | 1997 | https://conductscience.org/library/papers/9174173 | PubMed |
| 19 | 1607000 | Pharmacokinetics of meropenem in subjects with renal insufficiency. | Eur J Clin Pharmacol | 1992 | https://conductscience.org/library/papers/1607000 | PubMed |
| 20 | 2055812 | Pharmacokinetics of meropenem and its metabolite ICI 213,689 in healthy subjects with known renal metabolism of imipenem. | J Antimicrob Chemother | 1991 | https://conductscience.org/library/papers/2055812 | PubMed |
Cited by27
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 87 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42730518 | Integrating CRRT as a Virtual Organ Into Physiologically Based Pharmacokinetic Modeling to Optimize Antimicrobial Dosing in Septic Patients. | CPT Pharmacometrics Syst Pharmacol | 2026 | https://conductscience.org/library/papers/42730518 | PubMed |
| 41792368 | Development and validation of a machine learning model for individualised meropenem dosing in CRRT patients. | Sci Rep | 2026 | https://conductscience.org/library/papers/41792368 | PubMed |
| 40143863 | Phage-antibiotic combinations against Klebsiella pneumoniae: impact of methodological approaches on effect evaluation. | Front Microbiol | 2025 | https://conductscience.org/library/papers/40143863 | PubMed |
| 37630297 | Analytical and Clinical Validation of Assays for Volumetric Absorptive Microsampling (VAMS) of Drugs in Different Blood Matrices: A Literature Review. | Molecules | 2023 | https://conductscience.org/library/papers/37630297 | PubMed |
| 36005753 | Population Pharmacokinetic Meta-Analysis and Dosing Recommendation for Meropenem in Critically Ill Patients Receiving Continuous Renal Replacement Therapy. | Antimicrob Agents Chemother | 2022 | https://conductscience.org/library/papers/36005753 | PubMed |
| 31355341 | Ω76: A designed antimicrobial peptide to combat carbapenem- and tigecycline-resistant Acinetobacter baumannii. | Sci Adv | 2019 | https://conductscience.org/library/papers/31355341 | PubMed |
| 30118674 | Beta-lactam carryover in arterial and central venous catheters is negligible. | Clin Chim Acta | 2018 | https://conductscience.org/library/papers/30118674 | PubMed |
| 30094712 | A Robust Statistical Approach to Analyse Population Pharmacokinetic Data in Critically Ill Patients Receiving Renal Replacement Therapy. | Clin Pharmacokinet | 2019 | https://conductscience.org/library/papers/30094712 | PubMed |
| 30082292 | Ex Vivo Characterization of Effects of Renal Replacement Therapy Modalities and Settings on Pharmacokinetics of Meropenem and Vaborbactam. | Antimicrob Agents Chemother | 2018 | https://conductscience.org/library/papers/30082292 | PubMed |
| 26997934 | Pharmacokinetics of Continuous Infusion Meropenem With Concurrent Extracorporeal Life Support and Continuous Renal Replacement Therapy: A Case Report. | J Pediatr Pharmacol Ther | 2016 | https://conductscience.org/library/papers/26997934 | PubMed |
| 26711775 | Doripenem Treatment during Continuous Renal Replacement Therapy. | Antimicrob Agents Chemother | 2015 | https://conductscience.org/library/papers/26711775 | PubMed |
| 26124172 | Meropenem population pharmacokinetics in critically ill patients with septic shock and continuous renal replacement therapy: influence of residual diuresis on dose requirements. | Antimicrob Agents Chemother | 2015 | https://conductscience.org/library/papers/26124172 | PubMed |
| 25881576 | A multicenter study on the effect of continuous hemodiafiltration intensity on antibiotic pharmacokinetics. | Crit Care | 2015 | https://conductscience.org/library/papers/25881576 | PubMed |
| 25042938 | Beta-lactam dosing in critically ill patients with septic shock and continuous renal replacement therapy. | Crit Care | 2014 | https://conductscience.org/library/papers/25042938 | PubMed |
| 24643839 | [Pharmacokinetic and pharmacodynamic aspects in antibiotic treatment]. | Med Klin Intensivmed Notfmed | 2014 | https://conductscience.org/library/papers/24643839 | PubMed |
| 24419341 | Single-dose pharmacokinetics of cidofovir in continuous venovenous hemofiltration. | Antimicrob Agents Chemother | 2014 | https://conductscience.org/library/papers/24419341 | PubMed |
| 22839761 | Does Beta-lactam Pharmacokinetic Variability in Critically Ill Patients Justify Therapeutic Drug Monitoring? A Systematic Review. | Ann Intensive Care | 2012 | https://conductscience.org/library/papers/22839761 | PubMed |
| 21649882 | Recommended β-lactam regimens are inadequate in septic patients treated with continuous renal replacement therapy. | Crit Care | 2011 | https://conductscience.org/library/papers/21649882 | PubMed |
| 20479205 | Meropenem dosing in critically ill patients with sepsis receiving high-volume continuous venovenous hemofiltration. | Antimicrob Agents Chemother | 2010 | https://conductscience.org/library/papers/20479205 | PubMed |
| 18307371 | Population pharmacokinetics of meropenem in critically ill patients undergoing continuous renal replacement therapy. | Clin Pharmacokinet | 2008 | https://conductscience.org/library/papers/18307371 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/9736573
GET https://conductscience.org/api/papers/v1/9736573/references?page=2